Devices › Device types
FDA product code FAJ · class 2 · Gastroenterology, Urology
Cystoscope and accessories, flexible/rigid: medical device reports filed with FDA
11,197 reports carry this product code, 1993–2026; 6 brands with a page.
- 11,197
- reports with this product code
- 0% of all MAUDE reports
- 6,314
- reports, 12 months to August 2026
- 1,199 in the 12 months before
- 92.6%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code FAJ is FDA's classification for "Cystoscope and accessories, flexible/rigid" (gastroenterology, Urology panel), a class 2 device. 11,197 medical device reports carry this product code, 0% of the MAUDE database, from November 1993 to August 2026.
6,314 reports arrived in the 12 months to August 2026, up 427% from 1,199 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (92.6%), injury (7%) and other (0.3%). 6 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Cysto-Nephro Videoscope | 5,273 | 3,906 | 0% | 94.9% |
| Oes Cystonephrofiberscope | 1,911 | 1,093 | 0% | 93.3% |
| Visera Cysto-Nephro Videoscope | 1,747 | 1,108 | 0% | 89.8% |
| Halogen Light Source | 208 | 55 | 0% | 100% |
| Stryker | 1 | 5 | 1.3% | 46.3% |
| Uretero-Reno Fiberscope | 1 | 1,053 | 0% | 95.7% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Shirakawa Olympus | 8,321 | 74.3% |
| Hoya Pentax Tokyo Office | 497 | 4.4% |
| Aizu Olympus | 240 | 2.1% |
| Olympus Medical Systems | 211 | 1.9% |
| Karl Storz Se & Kg | 208 | 1.9% |
| Olympus Winter & Ibe | 92 | 0.8% |
| Olympus Medical System | 48 | 0.4% |
| Richard Wolf | 8 | 0.1% |
| Olympus Medical Systems Hinode Plant | 6 | 0.1% |
| Gyrus Acmi | 3 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Detachment of device or device componentpart of the device came off | 3,167 | 28.3% |
| Failure to clean adequately | 985 | 8.8% |
| Corrodedthe device corroded | 814 | 7.3% |
| Device reprocessing problem | 803 | 7.2% |
| Loss of or failure to bond | 787 | 7% |
| Breakthe device broke | 710 | 6.3% |
| Microbial contamination of device | 569 | 5.1% |
| No display/image | 410 | 3.7% |
| Material separation | 350 | 3.1% |
| Peeled/delaminated | 298 | 2.7% |
| Material deformation | 260 | 2.3% |
| Degraded | 249 | 2.2% |
| Material split, cut or torn | 244 | 2.2% |
| Poor quality image | 225 | 2% |
| Crackthe device cracked | 209 | 1.9% |
| Fluid/blood leak | 209 | 1.9% |
| Contamination | 155 | 1.4% |
| Erratic or intermittent display | 134 | 1.2% |
| Loose or intermittent connection | 131 | 1.2% |
| Material fragmentation | 126 | 1.1% |
Questions about cystoscope and accessories, flexible/rigid reports
What is product code FAJ?
FDA's classification code for "Cystoscope and accessories, flexible/rigid", class 2, reviewed by the gastroenterology, Urology panel. Every device report carries the product code of the device involved.
How many reports carry this code?
11,197 reports through August 2026, 6,314 of them in the latest 12 months.
Which brands appear most often?
Cysto-Nephro Videoscope (5,273), Oes Cystonephrofiberscope (1,911), Visera Cysto-Nephro Videoscope (1,747), Halogen Light Source (208) and Stryker (1). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.